Professor John Prins is an active clinician-scientist, a key opinion leader in diabetes and endocrinology in Australia and sits on numerous national and international scientific, clinical and educational committees and boards for the National Health and Medical Research Council (NHMRC), non-government organisations and industry.Professor Prins undertook his clinical training in endocrinology in Brisbane and then completed a PhD in adipose tissue biology at The University of Queensland (UQ). Then followed a postdoctoral research appointment at the University of Cambridge, UK, based at Addenbrooke’s Hospital.
He returned to Brisbane in 1998 after being awarded a Wellcome International Senior Research Fellowship.In 2004 he was Founder/Director of the UQ Centre for Diabetes and Endocrine Research, one of the most prominent and successful groups on the Princess Alexandra Hospital campus, which merged with the UQ Centre for Immunology and Cancer Research (CICR) in January 2007 to form the UQ Diamantina Institute. In 2009 Professor Prins was appointed CEO/Director of Mater Research. He was also Professor of Endocrinology at UQ and is a Senior Staff Endocrinologist at the Princess Alexandra Hospital.In 2018 Prof Prins was appointed Head of the Melbourne Medical School and Professor of Medicine at the University of Melbourne. He also has part-time clinical appointments in Endocrinology at the Royal Melbourne Hospital, Goulbourne Valley Health and Rumbalara.Professor Prins has substantial commercialisation experience, holds four international patents and was founder and scientific director of a spin-out biotech company—Adipogen Pty Ltd. He sits on numerous Australian and Global Pharmaceutical Scientific & Clinical Advisory Boards. His current corporate roles include directorships of Metro South Hospital and Health Service ($2.6b) and the Centre for Eye Research Australia. Professor Prins is actively involved in undergraduate and post-graduate teaching and training and has ongoing research interests in obesity, diabetes and intellectual disability. His current research focus is early-stage drug development in Type 2 Diabetes and in Non-Alcoholic Fatty Liver Disease. His research has attracted substantial government, NGO and Industry funding. He has published over 150 papers with over 11,000 citations and has an H index of 48 (Web of Science).
Find out more about John Prins' experience
John Prins' highlights
FEATURED Journal article
Sex Differences in the Risk of Barrett Esophagus Associated With the Metabolic Effects of Obesity.
Read moreJohn Prins' selected work
Scholarly Works
Displaying the 184 most recent scholarly works by John Prins.
Keyword Analysis
Honours, Awards and Fellowships
FAHMS - Fellow of the Australasian Academy of Health Science
FRACP - Fellow of the Royal Australasian College of Physicians
Credentials
Positions
Head Of School
Melbourne Medical School
Education
Doctor of Philosophy (Medicine)
University of Queensland
Bachelor of Medicine, Bachelor of Surgery
The University of Queensland